down arrow

West Pharmaceutical Services, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US9553061055
USD
281.77
-2.54 (-0.89%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,892.70
2,951.10
2,885.50
2,830.70
2,146.70
1,843.60
1,718.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,892.70
2,951.10
2,885.50
2,830.70
2,146.70
1,843.60
1,718.00
Raw Material Cost
1,890.50
1,818.40
1,746.60
1,657.30
1,378.80
1,234.80
1,171.70
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.90
8.80
7.60
8.50
8.50
8.00
8.10
Selling and Distribution Expenses
338.50
353.40
316.90
361.90
302.00
272.70
262.90
Other Expenses
6.62
5.96
5.09
4.43
3.84
3.09
3.22
Total Expenditure (Excl Depreciation)
2,298.10
2,240.20
2,122.00
2,072.00
1,727.70
1,546.40
1,474.90
Operating Profit (PBDIT) excl Other Income
594.6
710.9000000000001
763.5
758.7
419
297.2
243.1
Other Income
12.80
9.70
-39.80
2.60
-5.60
10.00
12.20
Operating Profit (PBDIT)
762.80
857.90
844.30
883.60
522.50
410.60
371.40
Interest
2.90
8.80
7.60
8.50
8.50
8.00
8.10
Exceptional Items
-19.00
-13.80
-36.20
-3.90
-3.60
-7.40
-18.20
Gross Profit (PBDT)
1,002.20
1,132.70
1,138.90
1,173.40
767.90
608.80
546.30
Depreciation
155.40
137.30
120.60
122.30
109.10
103.40
104.40
Profit Before Tax
585.50
698.00
679.90
748.90
401.30
291.80
240.70
Tax
107.50
122.30
114.70
107.20
72.50
59.00
41.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
492.70
593.40
585.90
661.80
346.20
241.70
206.90
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
492.70
593.40
585.90
661.80
346.20
241.70
206.90
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
492.70
593.40
585.90
661.80
346.20
241.70
206.90
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.25
0.25
0.25
0.25
0.25
0.25
0.25
Reserves
2,682.30
2,881.00
2,684.90
2,335.40
1,854.50
1,573.20
1,396.30
Earnings per share (EPS)
6.69
7.88
7.73
8.67
4.57
3.21
2.74
Diluted Earnings per share
6.69
7.88
7.73
8.67
4.57
3.21
2.74
Operating Profit Margin (Excl OI)
20.56%
24.09%
26.46%
26.8%
19.52%
16.12%
14.83%
Gross Profit Margin
25.61%
28.3%
27.74%
30.78%
23.78%
21.44%
20.09%
PAT Margin
17.03%
20.11%
20.3%
23.38%
16.13%
13.11%
12.04%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -1.98% vs 2.27% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -16.97% vs 1.28% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -11.58% vs -4.06% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -67.05% vs 15.79% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of West Pharmaceutical Services, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
2,892.70
19,672.00
-16,779.30
-85.30%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,892.70
19,672.00
-16,779.30
-85.30%
Raw Material Cost
1,890.50
11,518.00
-9,627.50
-83.59%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.90
520.00
-517.10
-99.44%
Selling and Distribution Expenses
338.50
3,887.00
-3,548.50
-91.29%
Other Expenses
6.62
79.10
-72.48
-91.63%
Total Expenditure (Excl Depreciation)
2,298.10
16,716.00
-14,417.90
-86.25%
Operating Profit (PBDIT) excl Other Income
594.60
2,956.00
-2,361.40
-79.88%
Other Income
12.80
455.00
-442.20
-97.19%
Operating Profit (PBDIT)
762.80
3,991.00
-3,228.20
-80.89%
Interest
2.90
520.00
-517.10
-99.44%
Exceptional Items
-19.00
-310.00
291.00
93.87%
Gross Profit (PBDT)
1,002.20
8,154.00
-7,151.80
-87.71%
Depreciation
155.40
580.00
-424.60
-73.21%
Profit Before Tax
585.50
2,581.00
-1,995.50
-77.31%
Tax
107.50
531.00
-423.50
-79.76%
Provisions and contingencies
0
0
0.00
Profit After Tax
492.70
1,993.00
-1,500.30
-75.28%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
492.70
1,993.00
-1,500.30
-75.28%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
57.00
-57.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
492.70
2,050.00
-1,557.30
-75.97%
Equity Capital
0
0
0.00
Face Value
0.25
0.01
0.00
Reserves
2,682.30
8,447.00
-5,764.70
-68.25%
Earnings per share (EPS)
6.69
4.34
2.35
54.15%
Diluted Earnings per share
6.69
4.34
2.35
54.15%
Operating Profit Margin (Excl OI)
20.56%
15.03%
0.00
5.53%
Gross Profit Margin
25.61%
16.07%
0.00
9.54%
PAT Margin
17.03%
10.13%
0.00
6.90%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 289.27 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -1.98% vs 2.27% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 49.27 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -16.97% vs 1.28% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 75.00 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -11.58% vs -4.06% in Dec 2023

Annual - Interest
Interest 0.29 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -67.05% vs 15.79% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.56%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."